Thrombin-induced platelet activation is inhibited by high- and low- molecular-weight heparin

Circulation

Volumn 99, Issue 25, 1999, Pages 3308-3314

  De Candia, E ^a   De Cristofaro, R ^a   Landolfi, R ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Glycoproteins; Heparin; Platelets; Receptors

Indexed keywords

CALCIUM ION; GLYCOPROTEIN IB; HEPARIN; HEPARIN DERIVATIVE; HEPARIN FRACTION; LOW MOLECULAR WEIGHT HEPARIN; THROMBIN;

ARTICLE; CALCIUM MOBILIZATION; CALCIUM TRANSPORT; DRUG BINDING SITE; DRUG EFFECT; DRUG POTENCY; HEPARINIZATION; HUMAN; HUMAN TISSUE; HYDROLYSIS; MOLECULAR WEIGHT; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION INHIBITION;

EID: 0033614851     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.99.25.3308     Document Type: Article

References (30)

1. Vu T-K, Hung D, Wheaton V, Coughlin S. Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell. 1991;64:1057-1068.
2. Khan ML, Zheng Y-W, Huang W, Bigornia V, Zeng D, Moff S, Farese RV Jr, Tam C, Coughlin SR. A dual thrombin receptor system for platelet activation. Nature. 1998;394:690-694.
3. De Marco L, Mazzucato M, Masotti A, Ruggeri ZM. Localization and characterization of an α-thrombin binding site on platelet glycoprotein Ib α. J Biol Chem. 1994;269:6478-6484.
4. Handa M, Titani K, Holland LZ, Roberts JR, Ruggeri ZM. The von Willebrand factor-binding domain of platelet membrane glycoprotein Ib: characterization by monoclonal antibodies and partial amino acid sequence analysis of proteolytic fragments. J Biol Chem. 1986;261:12579-12585.
5. 2+] induced by α-thrombin. Biochemistry. 1996;35:906-914.
6. De Marco L, Mazzucato M, Masotti A, Fenton JW II, Ruggeri ZM. Function of glycoprotein Ibα in platelet activation induced by a-thrombin. J Biol Chem. 1991;266:23776-23783.
7. Bode W, Turk D, Karshikov A. The refined 1.9-Å x-ray crystal structure of d-Phe-Pro-Arg chloromethylketone-inhibited human α-thrombin: structure, analysis, overall structure, electrostatic properties, detailed active-site geometry, and structure-function relationship. Protein Sci. 1992;1:426-471.
8. De Candia E, De Cristofaro R, De Marco L, Mazzucato M, Picozzi M, Landolfi R. Thrombin interaction with platelet GpIb: role of the heparin binding domain. Thromb Haemost. 1997;77:735-740.
9. De Cristofaro R, De Candia E, Croce G, Morosetti R, Landolfi R. Binding of human α-thrombin to platelet GpIb: energetics and functional effects. Biochem J. 1998;332:643-650.
10. De Cristofaro R, Rocca B, Bizzi B, Landolfi R. The linkage between binding of the C-terminal domain of hirudin and amydase activity in human α-thrombin. Biochem J. 1993;289:475-480.
11. T-thrombin. J Biol Chem. 1989;264:18419-18425.
12. Griffith MJ. Kinetics of the heparin-enhanced antithrombin III/thrombin reaction. J Biol Chein. 1982;257:7360-7365.
13. 2Cl-A selective affinity label for thrombin. Thromb Res. 1979;14:969-973.
14. De Cristofaro R, De Candia E, Picozzi M, Landolfi R. Conformational transitions linked to active site ligation in human thrombin: effect on the interaction with fibrinogen and the cleavable platelet receptor. J Mol Biol. 1995;245:447-458.
15. Ward CM, Andrews RK, Smith AI, Berndt MC. Mocarhagin, a novel cobra venom metalloproteinase, cleaves the platelet von Willebrand factor receptor glycoprotein Ibα: identification of the sulfated tyrosine/anionic sequence Tyr-276-Glu-282 of glycoprotein Ibα as a binding site for von Willebrand factor and α-thrombin. Biochemistry. 1996;35:4929-4938.
16. Bouton MC, Jandrot-Perrus M, Moog S, Cazenave JP, Guillin MC, Lanza F. Thrombin interaction with recombinant N-terminal extracellular domain of the thrombin receptor in an acellular system. Biochem J. 1995;305:635-641.
17. Olson ST, Halvorson HR, Björk I. Quantitative characterization of the thrombin-heparin interaction. J Biol Chem. 1991;266:6342-6352.
18. De Cristofaro R, De Candia E, Landolfi R. Effect of high- and low-molecular-weight heparins on thrombin-thrombomodulin interaction and protein C activation. Circulation. 1998;98:1297-1301.
19. Chow TW, Hellums JD, Moake JL, Kroll MH. Shear stress-induced von Willebrand factor binding to glycoprotein Ib initiates calcium influx associated with aggregation. Blood. 1992;80:113-120.
20. 2+ responses of protease-treated human platelets activated with a-thrombin and the tethered ligand peptide. Biochemistry. 1996;35:915-921.
21. Eika C. The platelet aggregating effect of eight commercial heparins. Scand J Haematol. 1972;9:480-482.
22. Salzman EW, Rosenberg RD, Smith MH, Lindon JN, Favreau L. Effects of heparin and heparin fractions on platelet aggregation. J Clin Invest. 1980;65:64-73.
23. Landolfi R, De Candia E, Rocca B, Ciabattoni G, Antinori A, Masetti R, Patrono C. Effects of unfractionated and low molecular weight heparins on platelet thromboxane biosynthesis "in vivo." Thromb Haemost. 1994; 72:942-946.
24. Xiao Z, Théroux P. Platelet activation with unfractionated heparin at therapeutic concentrations and comparison with a low-molecular-weight heparin and with a direct thrombin inhibitor. Circulation. 1998;97:251-256.
25. Levine MN, Hirsh J. Haemorrhagic complications of anticoagulant therapy. Semin Thromb Haemost. 1986;12:39-57.
26. Heiden D, Mielke CH, Rodvien R. Impairment by heparin of primary haemostasis and platelet (C14) 5-hydroxytryptamine release. Br J Haematol. 1977;36:427-436.
27. Fernandez F, N'Guyen P, VanRyn J, Ofosu FA, Hirsh J, Buchanan MR. Hemorrhagic doses of heparin and other glycosaminoglycans induce a platelet defect. Thromb Res. 1986;43:491-495.
28. Theroux P, Ouimet H, McCans J, Latour JG, Joly P, Levy G, Pelletier E, Juneau M, Stasiak J, deGuise P, Pelletier GB, Rinzler D, Waters DD. Aspirin, heparin, or both to treat unstable angina. N Engl J Med. 1988; 319:1105-1111.
29. Tollefsen DM, Blinder MA. Heparin. In: Hoffman R, Benz EJ Jr, Shattil SJ, Furie B, Cohen HJ, Silberstein LE, eds. Hematology: Basic Principles and Practice. New York, NY: Churchill Livingstone; 1995;1802-1813.
30. Sobel M, McNeill P, Carlson PL, Kermode JC, Adelman B, Conroy R, Marques D. Heparin inhibition of von Willebrand factor-dependent platelet function in vitro and in vivo. J Clin Invest. 1991;87:1787-1793.